Cancer, Metabolism, and Ketosis: A Systems Biology Paradigm for Complementary Therapy

Explore the synergy of ketogenic diet & traditional cancer treatments, focusing on metabolic interventions & considerations in breast cancer.

#CancerResearch #KetogenicDiet #diet #keto #cancer #metabolism #wellness #exogenousketones

Introduction

Cancer, a multifaceted and complex disease, has long been the focus of extensive research and evolving treatment modalities. Traditional treatments such as chemotherapy, radiation therapy, immunotherapy, and surgery have been the cornerstone of cancer management. However, emerging evidence suggests that metabolic and ketogenic approaches can complement these conventional therapies (Barrea et al., 2022; Weber et al., 2020).

The ketogenic diet, characterized by high fat, low carbohydrate, and moderate protein intake, induces a metabolic state of ketosis. This state has been theorized to “starve” cancer cells by altering the metabolic environment, potentially inhibiting tumor growth (Barrea et al., 2022). A growing body of research, including studies by Erickson et al. (2017) and Weber et al. (2018), has begun to shed light on the potential benefits and mechanisms of the ketogenic diet in cancer therapy.

This essay explores and analyzes the synergy between the ketogenic diet and traditional treatments in cancer management. By delving into the metabolic characteristics of cancer cells, examining clinical trials, and discussing implementation strategies, we aim to provide a comprehensive overview of this emerging systems biology paradigm.

Understanding Cancer Metabolism

Cancer cells exhibit unique metabolic characteristics, often relying on glycolysis for energy production, even in the presence of oxygen?—?a phenomenon known as the Warburg effect. This metabolic shift creates a dependency on glucose, making interventions that reduce glucose availability, such as the ketogenic diet, a potential strategy for “starving” cancer cells (Barrea et al., 2022; Weber et al., 2020).

The Ketogenic Diet and?Cancer

The ketogenic diet induces a state of ketosis, where the body primarily utilizes ketone bodies for energy. This shift reduces glucose availability, potentially inhibiting the growth and proliferation of cancer cells (Erickson et al., 2017). Studies by Weber et al. (2018) further support this theory, demonstrating the ketogenic diet in cancer therapy.

Synergy with Traditional Treatments

Combining the ketogenic diet with traditional treatments such as chemotherapy and radiation therapy has shown promising results. Research by Plotti et al. (2020) indicates that dietary interventions can enhance the effects of chemotherapy, suggesting a synergistic relationship. However, challenges such as patient adherence and potential side effects necessitate further research and careful implementation (Mundi et al., 2021).

Exploring the ketogenic diet as a complementary therapy in cancer treatment is a burgeoning field, showing promising potential in altering cancer metabolism and enhancing the efficacy of traditional treatments. While challenges remain, the growing body of evidence underscores the importance of continued research and developing patient-centered implementation strategies.

References

• Barrea, L., Caprio, M., Tuccinardi, D., Moriconi, E., Di Renzo, L., Muscogiuri, G., Colao, A., Savastano, S., & OPERA group. (2022). Could ketogenic diet “starve” cancer? Emerging evidence. Critical Reviews in Food Science and Nutrition, 62(7), 1800–1821. https://doi.org/10.1080/10408398.2020.1847030
• Erickson, N., Boscheri, A., Linke, B., & Huebner, J. (2017). Systematic review: isocaloric ketogenic dietary regimes for cancer patients. Medical Oncology, 34(5), 72. https://doi.org/10.1007/s12032-017-0930-5
• Mundi, M. S., Mohamed Elfadil, O., Patel, I., Patel, J., & Hurt, R. T. (2021). Ketogenic diet and cancer: Fad or fabulous? JPEN Journal of Parenteral and Enteral Nutrition, 45(S2), 26–32. https://doi.org/10.1002/jpen.2226
• Plotti, F., Terranova, C., Luvero, D., Bartolone, M., Messina, G., Feole, L., Cianci, S., Scaletta, G., Marchetti, C., Di Donato, V., Fagotti, A., Scambia, G., Benedetti Panici, P., & Angioli, R. (2020). Diet and Chemotherapy: The Effects of Fasting and Ketogenic Diet on Cancer Treatment. Chemotherapy, 65(3–4), 77–84. https://doi.org/10.1159/000510839
• Weber, D. D., Aminazdeh-Gohari, S., & Kofler, B. (2018). Ketogenic diet in cancer therapy. Aging (Albany NY), 10(2), 164–165. https://doi.org/10.18632/aging.101382
• Weber, D. D., Aminzadeh-Gohari, S., Tulipan, J., Catalano, L., Feichtinger, R. G., & Kofler, B. (2020). Ketogenic diet in the treatment of cancer?—?Where do we stand? Molecular Metabolism, 33, 102–121. https://doi.org/10.1016/j.molmet.2019.06.026

Section 1: Understanding Cancer Metabolism

Cancer, one of the most formidable diseases, is characterized by uncontrolled cell growth and proliferation. A key aspect of cancer biology is the unique metabolic characteristics exhibited by cancer cells. These cells undergo a metabolic shift, relying predominantly on glycolysis for energy production even in the presence of oxygen, a phenomenon known as the Warburg effect (Weber et al., 2020). This reliance on glycolysis increases the demand for glucose, making cancer cells particularly vulnerable to interventions that alter glucose availability.

The metabolic reprogramming observed in cancer cells is not merely a byproduct of rapid cell proliferation but also a critical player in promoting tumor progression. Barrea et al. (2022) elucidate that the altered metabolism in cancer cells supports their survival, growth, and resistance to apoptosis, thereby contributing to tumor aggressiveness. The metabolic adaptations of cancer cells are multifaceted, involving changes in energy production pathways, nutrient uptake, and the synthesis of macromolecules necessary for cell growth.

Given the pivotal role of metabolism in cancer cell survival and progression, strategies aimed at targeting cancer cell metabolism have garnered significant attention. The ketogenic diet, characterized by low carbohydrate, high fat, and moderate protein intake, induces a state of ketosis in the body. This metabolic state reduces glucose availability, thereby potentially “starving” the glucose-dependent cancer cells (Barrea et al., 2022). The shift to ketone body utilization for energy in normal cells, while cancer cells remain largely dependent on glucose, creates a metabolic mismatch that can be exploited for therapeutic purposes.

Weber et al. (2020) further explore the implications of metabolic interventions, highlighting that the ketogenic diet can affect cancer cells by reducing insulin and insulin-like growth factor signaling, decreasing inflammation, and inducing oxidative stress in cancer cells. These alterations in the tumor microenvironment can potentially inhibit cancer cell growth and enhance the sensitivity of cancer cells to traditional therapies such as chemotherapy and radiation.

The exploration of metabolic interventions, particularly the ketogenic diet, as a complementary approach to cancer treatment is grounded in understanding the distinct metabolic characteristics of cancer cells. By exploiting the vulnerabilities of cancer cell metabolism, there is a promising potential to develop novel therapeutic strategies synergistic with existing treatments. However, it is imperative to continue rigorous research and clinical trials to fully comprehend the mechanisms, efficacy, and safety of metabolic interventions in cancer therapy.

References

• Barrea, L., Caprio, M., Tuccinardi, D., Moriconi, E., Di Renzo, L., Muscogiuri, G., Colao, A., Savastano, S., & OPERA group. (2022). Could ketogenic diet “starve” cancer? Emerging evidence. Critical Reviews in Food Science and Nutrition, 62(7), 1800–1821. https://doi.org/10.1080/10408398.2020.1847030
• Weber, D. D., Aminzadeh-Gohari, S., Tulipan, J., Catalano, L., Feichtinger, R. G., & Kofler, B. (2020). Ketogenic diet in the treatment of cancer?—?Where do we stand? Molecular Metabolism, 33, 102–121. https://doi.org/10.1016/j.molmet.2019.06.026

Section 2: The Ketogenic Diet and?Cancer

The ketogenic diet, a nutritional approach that has gained considerable attention in cancer research, is characterized by a high intake of fats, moderate proteins, and very low carbohydrates. This unique composition induces a metabolic state known as ketosis, where the body predominantly utilizes ketone bodies derived from fats for energy instead of glucose (Erickson et al., 2017). The shift from glucose metabolism to fat metabolism is not just a physiological adaptation but holds significant therapeutic potential, especially in cancer treatment.

Cancer cells exhibit a distinct metabolic phenotype, characterized by an increased reliance on glycolysis for energy production, even in the presence of oxygen?—?a phenomenon termed the Warburg effect. This heightened dependence on glucose renders cancer cells particularly susceptible to interventions that limit glucose availability, such as the ketogenic diet (Barrea et al., 2022). By reducing glucose levels and elevating ketone bodies, the ketogenic diet creates a unfavorable metabolic environment for cancer cell growth and survival.

Research by Barrea et al. (2022) delves into the mechanisms by which the ketogenic diet may “starve” cancer cells. The authors elucidate that the diet’s ability to lower blood glucose levels and insulin secretion creates a hostile environment for glucose-dependent cancer cells, potentially inhibiting tumor progression. Additionally, the ketogenic diet has been shown to modulate inflammation and reduce oxidative stress, further contributing to its anti-cancer effects.

Erickson et al. (2017) conducted a systematic review of isocaloric ketogenic dietary regimes for cancer patients, shedding light on the diet’s impact on cancer treatment outcomes. The review highlighted that when administered with standard cancer therapies, the ketogenic diet demonstrated potential benefits in tumor growth control and patient survival. However, the authors emphasized the need for larger, well-designed clinical trials to validate these findings and establish the diet’s efficacy and safety in cancer patients.

Weber et al. (2018) further explored the role of the ketogenic diet in cancer therapy, discussing its potential to target the metabolic vulnerabilities of cancer cells. The authors highlighted that the diet’s impact on cellular energy metabolism, growth factor signaling reduction, and tumor microenvironment modulation collectively contribute to its therapeutic potential.

In conclusion, the ketogenic diet emerges as a promising complementary approach in cancer therapy, with its ability to alter metabolic pathways and “starve” cancer cells. The growing body of evidence, including studies by Barrea et al. (2022), Erickson et al. (2017), and Weber et al. (2018), underscores the diet’s potential benefits and the necessity for continued research to understand its implications in cancer treatment fully.

References

• Barrea, L., Caprio, M., Tuccinardi, D., Moriconi, E., Di Renzo, L., Muscogiuri, G., Colao, A., Savastano, S., & OPERA group. (2022). Could ketogenic diet “starve” cancer? Emerging evidence. Critical Reviews in Food Science and Nutrition, 62(7), 1800–1821. https://doi.org/10.1080/10408398.2020.1847030
• Erickson, N., Boscheri, A., Linke, B., & Huebner, J. (2017). Systematic review: isocaloric ketogenic dietary regimes for cancer patients. Medical Oncology, 34(5), 72. https://doi.org/10.1007/s12032-017-0930-5
• Weber, D. D., Aminazdeh-Gohari, S., & Kofler, B. (2018). Ketogenic diet in cancer therapy. Aging (Albany NY), 10(2), 164–165. https://doi.org/10.18632/aging.101382

Section 3: Synergy with Traditional Treatments

Integrating nutritional interventions, such as the ketogenic diet, with traditional cancer treatments, including chemotherapy, radiation therapy, immunotherapy, and surgery, is a burgeoning area of research. The ketogenic diet’s metabolic alterations have been explored for their potential to enhance the efficacy of conventional therapies and improve patient outcomes.

A study by Plotti et al. (2020) delved into the synergistic effects of the ketogenic diet with chemotherapy. The research highlighted that combining dietary interventions, such as fasting and the ketogenic diet, with chemotherapy could potentially enhance the treatment’s anti-tumor effects. The study suggested that the metabolic stress induced by such diets could sensitize cancer cells to chemotherapy, thereby improving the treatment’s efficacy. The authors concluded that while the preliminary results are promising, further clinical trials are essential to validate the safety and effectiveness of this combined approach.

Mundi et al. (2021) explored the ketogenic diet’s role in cancer treatment, evaluating whether it is a passing trend or a substantial addition to cancer therapy. The authors discussed the diet's potential, including its ability to target cancer cell metabolism, reduce inflammation, and modulate the immune response. These mechanisms could potentially enhance the effects of traditional treatments by making cancer cells more susceptible to therapy-induced cell death. However, the authors also emphasized the challenges and considerations associated with implementing the ketogenic diet in cancer patients, including adherence, nutritional adequacy, and potential side effects.

The potential synergy between the ketogenic diet and traditional cancer treatments is grounded in understanding cancer cell metabolism and the body’s adaptive responses to nutritional alterations. The diet’s ability to create a hostile metabolic environment for cancer cells, coupled with the cytotoxic effects of therapies like chemotherapy and radiation, presents a multifaceted approach to cancer treatment. However, implementing such strategies necessitates a careful balance to ensure patient safety and nutritional well-being.

While exploring the ketogenic diet as a complementary therapy has yielded encouraging results, it is imperative to approach this integration with caution. The potential benefits must be weighed against the challenges, and individualized patient assessments are crucial to determine the appropriateness of this intervention. Continued research, clinical trials, and interdisciplinary collaboration are essential to unravel the complexities of this synergy and establish evidence-based guidelines for its application in cancer therapy.

References

• Plotti, F., Terranova, C., Luvero, D., Bartolone, M., Messina, G., Feole, L., Cianci, S., Scaletta, G., Marchetti, C., Di Donato, V., Fagotti, A., Scambia, G., Benedetti Panici, P., & Angioli, R. (2020). Diet and Chemotherapy: The Effects of Fasting and Ketogenic Diet on Cancer Treatment. Chemotherapy, 65(3–4), 77–84. https://doi.org/10.1159/000510839
• Mundi, M. S., Mohamed Elfadil, O., Patel, I., Patel, J., & Hurt, R. T. (2021). Ketogenic diet and cancer: Fad or fabulous? JPEN Journal of Parenteral and Enteral Nutrition, 45(S2), 26–32. https://doi.org/10.1002/jpen.2226

Section 4: Experimental Research and Clinical?Trials

The exploration of the ketogenic diet as a complementary therapy in cancer treatment has been bolstered by a series of experimental research studies and clinical trials. These studies have been instrumental in uncovering the potential benefits, mechanisms, and challenges associated with integrating the ketogenic diet into cancer treatment protocols.

One of the early experimental research studies conducted by HILLEMANN in 1953 investigated the relationship between diet and cancer incidence in golden hamsters (Mesocricetus auratus). The study compared cancer incidence and subsequent mortality among hamsters fed deficient, whole, and supplemental diets. Although conducted in an era when the understanding of cancer metabolism was in its infancy, this study laid the groundwork for future research on dietary interventions and their impact on cancer development and progression.

More recent studies have delved deeper into the potential health benefits of the ketogenic diet. A narrative review by Dowis & Banga (2021) explored the various health benefits of the ketogenic diet, including its potential role in cancer treatment. The review highlighted the diet’s ability to induce metabolic changes, reduce inflammation, and modulate immune responses, which could collectively contribute to its anti-cancer effects. The authors emphasized the need for further research to fully understand the diet’s therapeutic potential and optimal implementation in clinical settings.

Lane et al. (2021) conducted a comprehensive assessment of the ketogenic diet’s role in cancer treatment, providing research recommendations based on their findings. The study evaluated the evidence and identified areas where additional research is needed to establish the diet’s efficacy and safety in cancer patients. The authors underscored the importance of well-designed clinical trials to validate the ketogenic diet as a viable complementary therapy and to develop evidence-based guidelines for its use in cancer treatment.

The findings and implications of these studies are pivotal in advancing our understanding of the ketogenic diet’s role in cancer therapy. They highlight the potential benefits of metabolic interventions, underscore the need for rigorous research, and guide the direction of future clinical trials. Integrating the ketogenic diet into cancer treatment protocols holds promise but necessitates a careful and evidence-based approach to ensure patient safety and optimize therapeutic outcomes.

References

• HILLEMANN, H. H. (1953). Experimental research on the relation between diet and cancer; comparisons of cancer incidence and subsequent mortality in deficient, whole and supplemental diet fed golden hamsters (Mesocricetus auratus). International Record of Medicine and General Practice Clinics, 166(8), 311–6.
• Dowis, K., & Banga, S. (2021). The Potential Health Benefits of the Ketogenic Diet: A Narrative Review. Nutrients, 13(5), 1654. https://doi.org/10.3390/nu13051654
• Lane, J., Brown, N. I., Williams, S., Plaisance, E. P., & Fontaine, K. R. (2021). Ketogenic Diet for Cancer: Critical Assessment and Research Recommendations. Nutrients, 13(10), 3562. https://doi.org/10.3390/nu13103562

Section 5: Patient Education and Implementation

Integrating the ketogenic diet into cancer treatment protocols necessitates a comprehensive patient education and implementation approach. Ensuring patients are well-informed about nutritional interventions' potential benefits, challenges, and nuances is paramount to achieving optimal therapeutic outcomes.

Barrea et al. (2022), along with the Obesity Programs of Nutrition, Education, Research and Assessment (OPERA) group, have emphasized the significance of patient education in implementing the ketogenic diet. Educating patients about the diet’s principles, its impact on metabolism, and the expected physiological changes is crucial for adherence and success. Tailoring the diet to individual patient needs, monitoring nutritional status, and addressing potential side effects are essential to effective implementation.

Effective implementation of the ketogenic diet in cancer patients also involves interdisciplinary collaboration among oncologists, dietitians, nutritionists, and other healthcare professionals. This collaborative approach ensures that the diet is integrated seamlessly with traditional cancer treatments, addressing potential interactions and optimizing patient well-being. Regular monitoring and adjustments to the diet based on patient response and treatment progress are vital to ensuring safety and efficacy.

Specific Considerations in Breast?Cancer

Breast cancer, one of the most prevalent forms of cancer, has been at the forefront of research exploring the potential benefits of the ketogenic diet as a complementary therapy. Several studies have delved into the effects of this metabolic intervention on quality of life, physical activity, biomarkers, and treatment outcomes in patients with breast cancer.

A randomized controlled clinical trial conducted by Khodabakhshi et al. (2020) investigated the beneficial effects of a ketogenic diet on quality of life, physical activity, and biomarkers in patients with breast cancer. The study aimed to elucidate whether this nutritional intervention could positively change patients' overall well-being undergoing cancer treatment. The findings of this trial indicated that the ketogenic diet had a favorable impact on certain aspects of quality of life and physical activity, suggesting its potential role in enhancing the well-being of breast cancer patients (Khodabakhshi et al., 2020).

Another study, the Diet Restriction and Exercise-induced Adaptations in Metastatic Breast Cancer (DREAM) study by Kirkham et al. (2021), focused on the combined effects of a short-term, calorie-restricted, ketogenic diet and exercise during intravenous chemotherapy. This randomized control trial assessed whether this multifaceted approach could improve outcomes in patients with metastatic breast cancer. The study’s design and rationale underscored the importance of exploring innovative strategies to optimize the effects of traditional cancer treatments and improve the quality of life for patients with advanced-stage breast cancer (Kirkham et al., 2021).

A systematic review by Jemal et al. (2021) delved into the therapeutic potential of ketogenic diets on breast cancer. The review analyzed various studies exploring the effects of this diet on breast cancer progression, treatment outcomes, and overall patient well-being. The authors concluded that while the ketogenic diet shows promise as a complementary therapy, further research and clinical trials are essential to validate its efficacy and safety in breast cancer patients (Jemal et al., 2021).

These studies highlight the growing interest in and potential of the ketogenic diet as a complementary therapy in breast cancer treatment. The diet’s ability to induce metabolic changes to improve quality of life and enhance the effects of traditional treatments makes it a promising avenue for further research. However, it is crucial to approach this intervention cautiously, ensuring that it is tailored to individual patient needs and implemented alongside standard care.

Exploring the ketogenic diet in the context of breast cancer is a testament to the evolving nature of cancer treatment strategies. Integrating nutritional interventions, such as the ketogenic diet, with traditional therapies aims to optimize treatment outcomes, improve patient well-being, and offer hope to those affected by this prevalent form of cancer.

Exploring the ketogenic diet as a complementary therapy in cancer treatment, particularly breast cancer, has unveiled promising avenues for enhancing therapeutic outcomes. Studies have highlighted the diet’s potential to improve quality of life, optimize the effects of traditional treatments, and induce favorable metabolic changes. However, continued research, well-designed clinical trials, and individualized patient assessments are essential to realize this nutritional intervention's therapeutic potential fully. The journey towards integrating the ketogenic diet into cancer treatment protocols is evolving, with the ultimate goal of improving patient outcomes and offering innovative solutions in the fight against cancer.

References

• Khodabakhshi, A., Seyfried, T. N., Kalamian, M., Beheshti, M., & Davoodi, S. H. (2020). Does a ketogenic diet have beneficial effects on quality of life, physical activity or biomarkers in patients with breast cancer: a randomized controlled clinical trial. Nutrition Journal, 19(1), 87. https://doi.org/10.1186/s12937-020-00596-y
• Kirkham, A. A., King, K., Joy, A. A., Pelletier, A. B., Mackey, J. R., Young, K., Zhu, X., Meza-Junco, J., Basi, S. K., Hiller, J. P., Brkin, T., Michalowski, B., Pituskin, E., Paterson, D. I., Courneya, K. S., & Thompson, R. B. (2021). Rationale and design of the Diet Restriction and Exercise-induced Adaptations in Metastatic breast cancer (DREAM) study: a 2-arm, parallel-group, phase II, randomized control trial of a short-term, calorie-restricted, and ketogenic diet plus exercise during intravenous chemotherapy versus usual care. BMC Cancer, 21(1), 1093. https://doi.org/10.1186/s12885-021-08808-2
• Jemal, M., Molla, T. S., & Asmamaw Dejenie, T. (2021). Ketogenic Diets and their Therapeutic Potential on Breast Cancer: A Systemic Review. Cancer Management and Research, 13, 9147–9155. https://doi.org/10.2147/CMAR.S339970

Conclusion:

Exploring the ketogenic diet as a complementary therapy in cancer treatment has unveiled a promising avenue for enhancing therapeutic outcomes. Clearly, it seems that there is a growing body of evidence that is supporting this eating strategy's ability to target the unique metabolic characteristics of cancer cells, induce a state of ketosis, and create a hostile environment for tumor growth (Barrea et al., 2022).

Thos of you who follow my writing, or have come to it from your own research, know that there is a growing understanding of the synergistic effects of following a strong KETO-LEANING Mediterranean diet for a multitude of inflamatory and neuropsychiatric disorders. I am hoping to add that to my literature reviews for a future article, in the context of cancer (I have already written about that for cardiovascular and neuropsychiatric disorders: see HERE and HERE, respectively).

Experimental research studies and clinical trials have highlighted the potential synergy between the ketogenic diet and traditional cancer treatments, including chemotherapy, radiation therapy, immunotherapy, and surgery. However, implementing this nutritional intervention requires a meticulous approach, focusing on patient education, adherence, and safety.

Some of us have looked at exogenous supplimentation of ketones (exogenous ketone supplementation), as it has been noted in the literature for those metabolically/energy intensive pathological states, to be beneficial. As with all supplimental things during a fragile health state, consult your physician and care team for what to do, and what not to do.

Reflecting on the potential of the ketogenic diet as complementary therapy, it is evident that this nutritional intervention holds promise in the multifaceted approach to cancer treatment. However, continued research, well-designed clinical trials, and interdisciplinary collaboration are essential to fully unravel the complexities of this therapy, establish evidence-based guidelines, and realize its therapeutic potential.

Future research and development should focus on elucidating the mechanisms of action, optimizing diet composition, assessing long-term safety, and evaluating the diet’s impact on different types of cancer. The journey towards integrating the ketogenic diet into cancer treatment is evolving, with the ultimate goal of improving patient outcomes and enhancing the quality of life for those affected by cancer.

References

• Barrea, L., Caprio, M., Tuccinardi, D., Moriconi, E., Di Renzo, L., Muscogiuri, G., Colao, A., Savastano, S., & OPERA group. (2022). Could ketogenic diet “starve” cancer? Emerging evidence. Critical Reviews in Food Science and Nutrition, 62(7), 1800–1821. https://doi.org/10.1080/10408398.2020.1847030

Desiderio Pina, MD, MPH - on LinkedIn

TheMindAndBodyDoc.com

Physician/Neuroscientist —?@mindandbodydoc

I provide compassionate care for children (5 years & older), adolescents, adults & families struggling with nutritional, drug, & neuropsychiatric problems.

Teaching is always a privilege, and I’ve been afforded such privilege to teach at various medical schools (MD & DO), residency programs (Psychiatry, Neurology, Family Practice, and Internal Medicine), and universities; I have participated in clinical and basic science research in the past, and am currently on staff at a few hospitals, but primarily care for patients via telemedicine.

I generally talk & write about things that catch my fancy in the news and from the recent medical literature.?

These include, but are not limited to:?#wellness,?#neurosciences,?#neuropsychiatry,?#culturalpsychiatry,?#ethnobotony,?#mycology,?#mycologicalmedicine,?#digitalhealthcare,?#healthcaremanagement, and?#psychoneuroendocrineimmunology